Pubblicazioni

Efficacy and Safety of Volanesorsen (ISIS 304801): the Evidence from Phase 2 and 3 Clinical Trials

2020 - CURRENT ATHEROSCLEROSIS REPORTS
Fogacci, F.; Norata, G. D.; Toth, P. P.; Arca, M.; Cicero, A. F. G.

Evaluation of efficacy and safety of antisense inhibition of apolipoprotein C-III with volanesorsen in patients with severe hypertriglyceridemia

2020 - EXPERT OPINION ON PHARMACOTHERAPY
D'Erasmo, L.; Gallo, A.; Di Costanzo, A.; Bruckert, E.; Arca, M.

ApoCIII: A multifaceted protein in cardiometabolic disease

2020 - METABOLISM, CLINICAL AND EXPERIMENTAL
D'Erasmo, L.; Di Costanzo, A.; Gallo, A.; Bruckert, E.; Arca, M.

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma